Skip to main content

Intraoperative direct hemoperfusion with a polymyxin-B immobilized fiber column for treatment of infective endocarditis

Abstract

Purpose

Endotoxin adsorption treatment (direct hemoperfusion using a polymyxin-B immobilized fiber column, or PMX-DHP) is now considered a useful option for treating severe sepsis. However, the efficacy of PMX-DHP for infective endocarditis (IE), in which the causative microorganisms are usually Gram-positive cocci, remains unclear. In the present study, we investigated the impact of intraoperative PMX-DHP on clinical parameters during the treatment of IE.

Methods

From November 2006 to December 2009, a total of 11 patients with active IE underwent emergent surgery using intraoperative PMX-DHP. The perioperative courses of these patients were compared with those of seven patients who underwent emergent surgery for active IE with the conventional method from January 2003 to October 2006.

Results

PMX-DHP was associated with a significant decrease in the postoperative catecholamine dose and duration. Intubation time and intensive care unit length of stay for the PMX-DHP group was significantly shorter than that for the conventional therapy group. There was also a significant difference in the number of failed organs postoperatively between the two groups.

Conclusion

Intraoperative PMX-DHP demonstrated several positive effects, such as a drastic decrease in the doses of inotropic agents and shortening of the duration of mechanical ventilation, in patients who underwent emergent surgery for active IE. Intraoperative PMX-DHP can be a useful option for the treatment of critically ill patients with IE.

This is a preview of subscription content, access via your institution.

References

  1. Aoki H, Kodama M, Tani T, Hanasawa K. Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-immobilized fiber. Am J Surg 1994;167:412–417.

    CAS  Article  PubMed  Google Scholar 

  2. Vincent JL, Laterre PF, Cohen J, Burchardi H, Bruining H, Lerma FA, et al. A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection. Shock 2005;23:400–405.

    CAS  Article  PubMed  Google Scholar 

  3. Cruz DN, Perazella MA, Bellomo R, de Cal M, Polanco N, Corradi V, et al. Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review. Crit Care 2007;11:R47.

    Article  PubMed  Google Scholar 

  4. Cruz DN, Antonelli M, Fumagalli R, Foltran F, Brienza N, Donati A, et al. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA 2009;301:2445–2452.

    CAS  Article  PubMed  Google Scholar 

  5. Murakami M, Miyauchi Y, Nishida M, Okada H, Hamano K. Direct hemoperfusion using polymyxin-B immobilized fiber for septic shock after cardiac surgery. Circ J 2009;73:658–661.

    CAS  Article  PubMed  Google Scholar 

  6. Asano M, Hanafusa Y, Otake H, Kazuma H. PMX-DHP therapy for a patient with infectious endocarditis. Jpn J Crit Care Endotoxemia 2005;9:247–250 (in Japanese with English abstract).

    Google Scholar 

  7. Totsugawa T, Kuinose M, Yoshitaka H, Ishii S, Tsushima Y, Ishida A. Intraoperative endotoxin adsorption as a new therapeutic option for mycotic aortic aneurysm. Circ J 2008;72:161–163.

    Article  PubMed  Google Scholar 

  8. Totsugawa T, Ozawa M, Kuinose M, Ishii S, Yoshitaka H, Tamaki T. Intraoperative endotoxin adsorption for visceral malperfusion complicating acute type A aortic dissection. Gen Thorac Cardiovasc Surg 2010;58:134–137.

    Article  PubMed  Google Scholar 

  9. Nakatani S, Mitsutake K, Hozumi T, Yoshikawa J, Akiyama M, Yoshida K, et al. Current characteristics of infective endocarditis in Japan: an analysis of 848 cases in 2000 and 2001. Circ J 2003;67:901–905.

    Article  PubMed  Google Scholar 

  10. Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients with Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008;118:e523–661.

    Article  PubMed  Google Scholar 

  11. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure: on behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996;22:707–710.

    CAS  Article  PubMed  Google Scholar 

  12. Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007;116:1736–1754.

    Article  PubMed  Google Scholar 

  13. Murphy GJ, Angelini GD. Side effects of cardiopulmonary bypass: what is the reality? J Card Surg 2004;19:481–488.

    CAS  Article  PubMed  Google Scholar 

  14. Aydin NB, Gercekoglu H, Aksu B, Ozkul V, Sener T, Kiygil I, et al. Endotoxemia in coronary artery bypass surgery: a comparison of the off-pump technique and conventional cardiopulmonary bypass. J Thorac Cardiovasc Surg 2003;125:843–848.

    Article  PubMed  Google Scholar 

  15. Rothenburger M, Soeparwata R, Deng MC, Berendes E, Schmid C, Tjan TD, et al. The impact of anti-endotoxin core antibodies on endotoxin and cytokine release and ventilation time after cardiac surgery. J Am Coll Cardiol 2001;38:124–130.

    CAS  Article  PubMed  Google Scholar 

  16. Mythen MG, Webb AR. The role of gut mucosal hypoperfusion in the pathogenesis of post-operative organ dysfunction. Intensive Care Med 1994;20:203–209.

    CAS  Article  PubMed  Google Scholar 

  17. Caty MG, Guice KS, Oldham KT, Remick DG, Kunkel SI. Evidence for tumor necrosis factor-induced pulmonary microvascular injury after intestinal ischemia-reperfusion injury. Ann Surg 1990;212:694–700.

    CAS  Article  PubMed  Google Scholar 

  18. Ohki S, Oshima K, Takeyoshi I, Matsumoto K, Morishita Y. Endotoxin removal with a polymyxin B-immobilized hemoperfusion cartridge improves cardiopulmonary function after cardiopulmonary bypass. J Surg Res 2008;145:74–79.

    CAS  Article  PubMed  Google Scholar 

  19. Iwama H, Komatsu T. Effect of an endotoxin-removing column containing immobilized polymyxin B fiber in a patient with septic shock from gram-positive infection. Acta Anaesthesiol Scand 1998;42:590–593.

    CAS  Article  PubMed  Google Scholar 

  20. Gao JJ, Xue Q, Papasian CJ, Morrison DC. Bacterial DNA and lipopolysaccharide induce synergistic production of TNFalpha through a post-transcriptional mechanism. J Immunol 2001;166:6855–6860.

    CAS  PubMed  Google Scholar 

  21. Ruud TE, Gundersen Y, Wang JE, Foster SJ, Thiemermann C, Aasen AO. Activation of cytokine synthesis by systemic infusions of lipopolysaccharide and peptidoglycan in a porcine model in vivo and in vitro. Surg Infect (Larchmt) 2007;8:495–503.

    Article  Google Scholar 

  22. Wang Y, Liu Y, Sarker KP, Nakashima M, Serizawa T, Kishida A, et al. Polymyxin B binds to anandamide and inhibits its cytotoxic effect. FEBS Lett 2000;470:151–155.

    CAS  Article  PubMed  Google Scholar 

  23. Kushi H, Miki T, Nakahara J, Okamoto K, Saito T, Tanjoh K. Hemoperfusion with an immobilized polymyxin B column reduces the blood level of neutrophil elastase. Blood Purif 2006;24:212–217.

    CAS  Article  PubMed  Google Scholar 

  24. Sakamoto Y, Mashiko K, Matsumoto H, Hara Y, Kutsukata N, Yamamoto Y. Relationship between effect of polymyxin B-immobilized fiber and high-mobility group box-1 protein in septic shock patients. ASAIO J 2007;53:324–328.

    CAS  Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Toshinori Totsugawa.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Totsugawa, T., Kuinose, M., Yoshitaka, H. et al. Intraoperative direct hemoperfusion with a polymyxin-B immobilized fiber column for treatment of infective endocarditis. Gen Thorac Cardiovasc Surg 59, 98–104 (2011). https://doi.org/10.1007/s11748-010-0700-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11748-010-0700-1

Key words

  • Endotoxin adsorption
  • Direct hemoperfusion
  • Polymyxin B-immobilized fiber column
  • Infective endocarditis